Ovid Therapeutics (OVID)
(Real Time Quote from BATS)
$3.20 USD
-0.01 (-0.31%)
Updated Apr 19, 2024 11:40 AM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/3/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | -29.41% |
ABR | 1.29 |
Earnings ESP
|
23.60% |
---|---|
Current Year | -0.65 |
Next Year | -0.20 |
EPS (TTM) | -0.75 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.14M | 0.15M | 0.61M | 11.60M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 0.17M | 0.19M | 0.82M | 22.33M |
Low Estimate | 0.10M | 0.10M | 0.40M | 0.87M |
Year ago Sales | 0.07M | 0.08M | 0.39M | 0.61M |
Year over Year Growth Est. | 92.86% | 81.25% | 55.62% | 1,801.64% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.21 | -0.65 | -0.20 |
# of Estimates | 4 | 3 | 5 | 4 |
Most Recent Consensus | -0.17 | -0.18 | -0.73 | -0.49 |
High Estimate | -0.17 | -0.18 | -0.04 | 1.01 |
Low Estimate | -0.27 | -0.24 | -0.90 | -0.85 |
Year ago EPS | -0.19 | -0.18 | -0.74 | -0.65 |
Year over Year Growth Est. | -15.79% | -16.67% | 12.16% | 69.85% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 4 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.21 | -0.65 | -0.20 |
7 Days Ago | -0.22 | -0.21 | -0.65 | -0.20 |
30 Days Ago | -0.24 | -0.22 | -0.64 | -0.10 |
60 Days Ago | -0.18 | -0.17 | -0.43 | -0.60 |
90 Days Ago | -0.18 | -0.17 | -0.43 | -0.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.18 | -0.73 | -0.49 |
Zacks Consensus Estimate | -0.22 | -0.21 | -0.65 | -0.20 |
Earnings ESP | 23.60% | 12.91% | -11.62% | -145.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.16 | -0.18 | -0.19 | NA |
Estimate | -0.17 | -0.18 | -0.21 | -0.18 | NA |
Difference | -0.05 | 0.02 | 0.03 | -0.01 | 0.00 |
Surprise | -29.41% | 11.11% | 14.29% | -5.56% | -2.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more